Peripheral Arterial Disease Education and ABI Training for Vascular Nurses Presented by The Society for Vascular Nursing Comprehensive In-Service Lecture Kit Supported by an educational grant from Bristol-Myers Squibb/Sanofi Partnership PERIPHERAL ARTERIAL DISEASE Education and ABI Training for Vascular Nurses A Train the Trainer Program The Ankle Brachial Index: The Key to Early Detection and Management of Peripheral Arterial Disease Acknowledgements Course Development – ABI Registry Task Force Diane Treat-Jacobson, Ph.D., R.N. Carolyn Robinson MSN, RN, CNP,CVN Marge Lovell RN, CCRC, CVN, BEd Patricia Lewis, MS, FNP, CVN M. Kate Schmidt, BSN, RN, CVN Contact Information Society for Vascular Nursing 203 Washington St., PMB 311 Salem, MA 01970 888-536-4786; 978-744-5005; Fax: 978-744-5029 Peripheral Arterial Disease and Claudication Peripheral Arterial Disease (PAD) A disorder caused by atherosclerosis that limits blood flow to the limbs Claudication A symptom of PAD characterized by pain, aching, or fatigue in working skeletal muscles. Claudication arises when there is insufficient blood flow to meet the metabolic demands in leg muscles of ambulating patients New PAD Guidelines Enhanced quality of patient care Increased recognition of the importance of atherosclerotic lower extremity PAD: – Prevalence – Cardiovascular risk – Quality of life Improved ability to detect and treat renal artery disease Improved ability to detect and treat AAA The evidence base has become increasingly robust, so that a data-driven care guideline is now possible Defining a Population “At Risk” for Lower Extremity PAD Age less than 50 years with diabetes, and one additional risk factor (e.g., smoking, dyslipidemia, hypertension, or hyperhomocysteinemia) Age 50 to 69 years and history of smoking or diabetes Age 70 years and older Leg symptoms with exertion (suggestive of claudication) or ischemic rest pain Abnormal lower extremity pulse examination Known atherosclerotic coronary, carotid, or renal artery disease Relative Prevalence of Peripheral Arterial Disease Age (years) Population (millions) PAD (millions) Claudication (millions) 40-59 68.9 2.1 0.9 60-69 19.8 1.6 0.8 70 24.8 4.7 113.5 8.4 2.5 4.2 Criqui MH et al. N Engl J Med. 1992;326:381-6. Hiatt W et al. Circulation. 1995;91:1472-9. Porter J. Mod Med. 1987;55:66-75. US Census Data, 1998 estimates. Web address www.census.gov/population/estimates/nation/infile2-1.txt Systemic Manifestations of Atherosclerosis • TIA • Ischemic stroke • Myocardial Infarction • Unstable angina pectoris • Renovascular hypertension • Erectile dysfunction • Claudication • Critical limb ischemia, rest pain, gangrene, amputation Prevalence of PAD NHANES1 Aged >40 years San 4.3% Diego2 11.7% Mean age 66 years NHANES1 14.5% Aged 70 years Rotterdam3 19.1% Aged >55 years Diehm4 In a primary care population defined by age and common risk factors, the prevalence of PAD was approximately one in three patients 19.8% Aged 65 years PARTNERS5 29% Aged >70 years, or 50–69 years with a history diabetes or smoking 0% 5% 10% 15% 20% 25% 30% NHANES=National Health and Nutrition Examination Study; PARTNERS=PAD Awareness, Risk, and Treatment: New Resources for Survival [program]. 1. Selvin E, Erlinger TP. Circulation. 2004;110:738-743. 2. Criqui MH et al. Circulation. 1985;71:510-515. 3. Diehm C et al. Atherosclerosis. 2004;172:95-105. 4. Meijer WT et al. Arterioscler Thromb Vasc Biol. 1998;18:185-192. 5. Hirsch AT et al. JAMA. 2001;286:1317-1324. 35% Prevalence of PAD Increases with Age Rotterdam Study (ABI <0.9)1 San Diego Study (PAD by noninvasive tests)2 Patients With P.A.D. (%) 60 50 40 30 20 10 0 55-59 60-64 65-69 70-74 75-79 80-84 85-89 Age Group, years ABI=ankle-brachial index 1. Meijer WT, et al. Arterioscler Thromb Vasc Biol. 1998;18:185-192. 2. Criqui MH, et al. Circulation. 1985;71:510-515. Gender Differences in the Prevalence of PAD 18 Prevalence (%) 16 14 12 6880 Consecutive Patients (61% Female) in 344 Primary Care Offices Women Men 10 8 6 4 2 0 <70 70–74 75–79 Age (years) Diehm C. Atherosclerosis. 2004;172:95-105. 80–74 >85 Diabetes Increases Risk of PAD Prevalence of PAD (%) 25 22.4* 19.9* 20 15 12.5 10 5 0 Normal glucose tolerance Impaired glucose tolerance Diabetes Impaired Glucose Tolerance was defined as oral glucose tolerance test value ≥140 mg/dL but <200 mg/dL. *P.05 vs normal glucose tolerance. Reprinted with permission from Lee AJ et al. Br J Haematol. 1999;105:648-654. www.blackwell-synergy.com Ethnicity and PAD: The San Diego Population Study % PAD 10 9 8 7 6 5 4 3 2 1 0 NHW Black Hispanic Asian NHW = Non-hispanic white Criqui et al. Circulation. 2005: 112: 2703-2707. Risk Factors for PAD Reduced Increased Smoking Diabetes Hypertension Hypercholesterolemia Hyperhomocysteinemia C-Reactive Protein Relative Risk 0 1 2 3 4 5 6 Hirsch AT, et al. J Am Coll Cardiol. 2006;47:e1-e192. Pathogenesis of Progressive Atherosclerosis Risk of Ischemic Events Previous MI – 5-7 times more likely to have another MI – 3-4 times more likely to have a stroke Previous stroke – 9 times more likely to have another stroke – 2-3 times more likely to have an MI PAD – 4 times more likely to have an MI – 2-3 times more likely to have stroke Long-term Survival in Patients With PAD 100 Survival (%) Normal subjects 75 Asymptomatic PAD 50 Symptomatic PAD Severe symptomatic PAD 25 0 2 4 6 8 10 12 Year Criqui MH et al. N Engl J Med. 1992;326:381-386. Copyright © 1992 Massachusetts Medical Society. All rights reserved. Contemporary PAD Rates of Myocardial Infarction and Death 3649 subjects (average age 64 yrs) followed up for 7.2 years 50 40 % 30 20 10 0 MI No PAD Asymptomatic PAD Death Symptomatic PAD Hooi JD, et al. J Clin Epid. 2004;57:294–300. Association Between ABI and All-Cause Mortality* Risk increases at ABI values below 1.0 and above 1.3 Total mortality (%) 80 70 N=5748 60 50 40 30 20 10 0 <0.61 (n=156) 0.61-0.70 0.71-0.80 0.81-0.90 0.91-1.00 1.01-1.10 1.11-1.20 1.21-1.30 1.31-1.40 (n=141) (n=186) (n=310) (n=709) (n=1750) (n=1578) Baseline ABI Age range=mid- to late-50s; *Median duration of follow-up was 11.1 (0.1–12) years. Adapted from O’Hare AM et al. Circulation. 2006;113:388-393. (n= 696) (n=156) >1.40 (n=66) A Risk Factor “Report Card” for all Individuals with Atherosclerosis Tobacco smoking Complete, immediate cessation Hypertension BP less than 130/85 mmHg Diabetes Hb A1C <7.0 Dyslipidemia LDL Cholesterol less than 100 mg/dl Raise HDL-c Lower Triglycerides Inactivity Follow activity guidelines Antiplatelet therapy (like aspirin or Plavix) is: Mandatory Pathway of Disability in Intermittent Claudication PAD Reduced muscle strength Poor walking ability and IC Disability Denervation, muscle-fiber atrophy, decreased type II fibers, decreased oxidative metabolism Cycle of deconditioning: decreased HDL, poorer glycemic control, poorer BP control Adapted from McDermott M. Am J Med. 1999;CE (I):18-24. Impact of PAD on Quality of Life PAD Diagnosis and Management Symptom Experience Limitation in Physical Functioning Limitation in Social Functioning Compromise of Self Uncertainty Adaptation SF-36 Scores in Health and Disease Intermittent claudication CHF No. of people 30 Chronic lung disease 34 36 38 40 Average adult 50 Physical Component Summary Score Average well adult 55 Location of Obstruction Influences Symptoms Obstruction in: Aorta or iliac artery Claudication in: Buttock, hip, thigh Femoral artery or branches Thigh, calf Popliteal artery Calf, ankle, foot Claudication: A Symptom of Peripheral Arterial Disease Exertional aching pain, cramping, tightness, fatigue Occurs in muscle groups, not joints (buttocks, hips, legs, calves) Reproducible from one day to the next on similar terrain Resolves completely with rest Occurs again at the same distance once activity has been resumed Symptoms in PAD Patients with PAD Symptomatic PAD ~39%1 Typical Symptoms (Intermittent Claudication) ~9% 1. 2. Asymptomatic PAD ~61%1 Atypical Symptoms ~91% American Heart Association. Heart Disease and Stroke Statistics—2005 Update. 2005. Hirsch AT, et al. JAMA. 2001;286:1317-1324. Clinical Assessment of Peripheral Arterial Disease Components of Clinical Assessment Complete history – Risk factor assessment – Activity assessment Review of medications Physical examination – Inspection of lower extremities – Pulse exam Questions for Patients Do you develop discomfort in your legs when you walk? – Cramping, aching, fatigue Do you get this pain when you are sitting standing, or lying? Do symptoms only start when you walk? Does the discomfort always occur at about the same distance? Do symptoms resolve once you stop walking? PAD Pulse Evaluation Right Left Femoral Popliteal Dorsalis pedis Posterior tibial Ankle–brachial index Note: 0-4 scale, where 0 = absent, 2 = Diminished, 4 = Normal Limits The Ankle-Brachial Index (ABI) The first diagnostic assessment that should be done to evaluate a patient for PAD after a pulse exam in the presence of risk factors or if claudication is suspected. Inexpensive, accurate and can be done in the primary care setting The ABI is 95% sensitive and 99% specific for PAD Predicts limb survival, potential for wound healing, and mortality The Ankle-Brachial Index (ABI) Indicated – In the absence of palpable pulses, or if pulses are diminished – In the presence or suspicion of claudication, foot pain at rest, or a non-healing foot ulcer – Age greater than 70 years of age, >50 years with risk factors (diabetes, smoking) Concept of ABI The systolic blood pressure in the leg should be approximately the same as the systolic blood pressure in the arm. Therefore, the ratio of systolic blood pressure in the leg vs the arm should be approximately 1 or slightly higher. Leg pressure ÷ Arm pressure ABI has been found to be 95% sensitive and 99% specific for angiographically diagnosed PAD. Adapted from Weitz JI, et al. Circulation. 1996;94:3026-3049. ≈1 Understanding the ABI Performed with patient resting in supine position All pressures are measured with a arterial Doppler and appropriately sized blood pressure cuff Both brachial pressures are measured Ankle pressures are measured using the posterior tibial and/or dorsalis pedis arteries Measuring the Ankle-Brachial Index (ABI) Step 1: Gather Equipment Needed Equipment needed: 1. Blood Pressure Cuff 2. Hand-held 5-10 MHz Doppler probe 3. Ultrasound Gel American Diabetes Association. Diabetes Care 2003: 26; 3333–3341. Measuring the Ankle-Brachial Index (ABI) Step 2: Position the Patient Place patient in supine position for 5 – 10 minutes minutes American Diabetes Association. Diabetes Care 2003: 26; 3333–3341. Measuring the Ankle-Brachial Index (ABI) Step 3: Measure the Brachial Blood Pressure 1. Place the blood pressure cuff on the arm above the elbow. 2. Apply gel to the skin surface. 3. Place the Doppler probe over the brachial pulse 4. Inflate the cuff to approx. 20 mm/hg above the point where systolic sounds are no longer heard. 5. Deflate the cuff slowly until the arterial signal returns (systolic pressure) 6. Repeat in the other arm American Diabetes Association. Diabetes Care 2003: 26; 3333–3341. Measuring the Ankle-Brachial Index (ABI) Step 4: Position the Cuff Above the Ankle Place blood pressure cuff just above the ankle of one leg, apply gel over the area of the dorsalis pedis artery Dormandy JA et al. J Vasc Surg. 2000;31:S1-S296. Measuring the Ankle-Brachial Index (ABI) Step 5: Measure the Pressure in the Dorsalis Pedis Artery 1. Place Doppler probe over the dorsalis pedis artery; inflate the cuff 2. Deflate the cuff; when the return of blood flow is detected, record this as the systolic pressure of the DP artery of that leg Dormandy JA et al. J Vasc Surg. 2000;31:S1-S296. Measuring the Ankle-Brachial Index (ABI) Step 6: Measure the Pressure in the Posterior Tibial Artery 1. Place gel and Doppler probe over the posterior tibial artery (below the cuff) 2. Measure the pressure, record as posterior tibial pressure for that leg Dormandy JA et al. J Vasc Surg. 2000;31:S1-S296. Measuring the Ankle-Brachial Index (ABI) Step 7: Repeat the Process in the Opposite Leg Repeat the same process in the other leg and record the pressures of the dorsalis pedis and posterior tibial arteries Dormandy JA et al. J Vasc Surg. 2000;31:S1-S296. Calculating the ABI Right Leg ABI Left Leg ABI Higher right-ankle pressure (DP or PT pulse) = Higher arm pressure (of either arm) Higher left-ankle pressure (DP or PT pulse) = Higher arm pressure (of either arm) ABI Interpretation ≤ 0.90 is diagnostic of peripheral arterial disease Hiatt WR. N Engl J Med. 2001;344:1608-1621. Calculating the ABI Example Calculation Right Leg ABI = Left Leg ABI 60 mm Hg 120 mm Hg Hiatt WR. N Engl J Med. 2001;344:1608-1621. 66 mm Hg = 120 mm Hg Calculating the ABI Example Calculation Right Leg ABI 60 mm Hg Left Leg ABI 66 mm Hg = 0.50 120 mm Hg 120 mm Hg = 0.55 ABI Interpretation ≤ 0.90 is diagnostic of peripheral arterial disease Hiatt WR. N Engl J Med. 2001;344:1608-1621. ABI Limitations Possible false negatives in patients with noncompressible arteries, such as some diabetics and elderly individuals Insensitive to very mild occlusive disease and iliac occlusive disease Not well correlated with functional ability and should be considered in conjunction with activity history or questionnaires Interpreting the Ankle–Brachial Index ABI 0.90–1.30 Interpretation Normal 0.70–0.89 Mild 0.40–0.69 Moderate 0.40 Severe >1.30 Noncompressible vessels Adapted from Hirsch AT. Family Practice Recertification. 2000;22:6-12. Referring to the Vascular Lab Caveats for referral to vascular lab • Assessment of the location and severity is desired • Patients with poorly compressible vessels • Normal ABI where there is high suspicion of PAD Vascular Lab Evaluation • Segmental pressures • Pulse volume recordings • Treadmill PAD Diagnosis Indications for Referral for Vascular Specialty Care Lifestyle-disabling claudication (refractory to exercise or pharmacotherapy) Rest pain Tissue loss Severity of ischemia Summary PAD is a common atherosclerotic disease associated with risk of cardiovascular ischemic events and significant functional disability PAD can be effectively assessed in the primary care setting by primary care nurses The ankle brachial index is an effective and efficient measurement tool for diagnosis of PAD Early detection of PAD allows for appropriate disease management and decreased likelihood of ischemic events and disease progression The Graying of U.S. Society Seniors 12.4 percent of the population Baby boomers will number 75 million 2030 – 20 percent will be over age 65 – 1/2 population > age 40 Nurse Competence in Aging Imperatives Moving to an aging society 85+ population > 8.9 million in 2030 Older adults – Utilize 50% of hospital days – 45% of the direct care – primary patient population of most specialty nurses. Geriatric preparation significantly improve health care to older adults. Classifying the Elderly ages 65 to 74 - the young old ages 75 to 84 - the middle old ages 85 and older - the old old Impact of Aging ↑risk of health ↑co-morbidities ↑ disabilities ↑dementia ↑seniors with chronic illness requiring care ↓quality of life Age Related Changes Cardiac Pulmonary Renal Gastrointestinal CNS Integument Cardiac Function Coronary artery blood flow – decreases 35% between ages 20 and 60. Cardiac output decreases Systolic and diastolic murmurs There is a decrease in cardiac responsiveness rate with exercise. Cardiovascular Function and Aging Central and peripheral circulation decreases Aerobic capacity decreases about 1% per year Maximum heart rate decreases about 1 beat per year Maximum stroke volume decreases Maximum cardiac output decreases Peripheral blood flow decreases Physiological Changes to the Body with Aging Heart muscle – Contractile strength and efficiency decreases – Left ventricular wall thickens Heart valves – fibrotic and sclerotic SA node and AV tracts – Infiltrated by fibrous tissue. Aortic and mitral valves – Calcify Changes in Blood Vessels Veins and arteries – dilate and stretch – decreased strength and elasticity. Peripheral arteries – Tortuous – Less resilient. Aorta and large arteries – stiffen Aorta – may lengthen and become tortuous. Blood Pressure Changes Systolic blood pressure – May rise disproportionately higher than diastolic. Changes in the cardiovascular system – Direct effects on other organs. Hypertension – Atherosclerotic changes in blood vessels – May result in the loss of vision, renal Strength Changes With Aging Maximal strength decreases Muscle mass decreases Total number and size of muscle fibers decreases Nervous system response slows Exercise and the Elderly 1996 report 30% of the elderly exercise regularly. Results in decreased risk for a number of chronic and debilitating illnesses. US Department of Health and Human Services Assess – Motivation. – Level of activity that a person is capable of doing, – Help him/ her to understand how to change Health Care for the Elderly Include – health promotion, – disease prevention, – health maintenance Anatomical and physiological changes – cardiovascular – Genitourinary – Neurological – musculoskeletal respiratory endocrine skin